Scott Michael Galovan

All filings by Scott Michael Galovan on record concern Avanos Medical, Inc., in the capacity of finance chief. We count 12 filings; the first trade dates from 6 March 2026 and the latest from 27 July 2026.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 28 July 2026, reports a share grant in Avanos Medical, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.